133 related articles for article (PubMed ID: 8019451)
1. Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.
Bearman SI; Mori M; Beatty PG; Meyer WG; Buckner CD; Petersen FB; Sanders JE; Anasetti C; Martin P; Appelbaum FR
Bone Marrow Transplant; 1994 Jan; 13(1):31-5. PubMed ID: 8019451
[TBL] [Abstract][Full Text] [Related]
2. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
3. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney.
Atkinson K; Dodds AJ; Concannon AJ; Milliken S; Downs K; Marshall G; Wilson F; Staniforth D
Aust N Z J Med; 1993 Oct; 23(5):450-7. PubMed ID: 8297273
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
[TBL] [Abstract][Full Text] [Related]
5. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
Bone Marrow Transplant; 1995 Apr; 15(4):619-25. PubMed ID: 7655390
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors.
Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA
Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692
[TBL] [Abstract][Full Text] [Related]
7. Comparison of engraftment in recipients of matched sibling of unrelated donor marrow allografts.
Davies SM; Ramsay NK; Haake RJ; Kersey JH; Weisdorf DJ; McGlave PB; Blazar BR
Bone Marrow Transplant; 1994 Jan; 13(1):51-7. PubMed ID: 8019453
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
9. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
[TBL] [Abstract][Full Text] [Related]
10. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
Filipovich AH; Stone JV; Tomany SC; Ireland M; Kollman C; Pelz CJ; Casper JT; Cowan MJ; Edwards JR; Fasth A; Gale RP; Junker A; Kamani NR; Loechelt BJ; Pietryga DW; Ringdén O; Vowels M; Hegland J; Williams AV; Klein JP; Sobocinski KA; Rowlings PA; Horowitz MM
Blood; 2001 Mar; 97(6):1598-603. PubMed ID: 11238097
[TBL] [Abstract][Full Text] [Related]
11. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
Anasetti C; Amos D; Beatty PG; Appelbaum FR; Bensinger W; Buckner CD; Clift R; Doney K; Martin PJ; Mickelson E
N Engl J Med; 1989 Jan; 320(4):197-204. PubMed ID: 2643045
[TBL] [Abstract][Full Text] [Related]
12. Marrow transplantation from related donors other than HLA-identical siblings.
Beatty PG; Clift RA; Mickelson EM; Nisperos BB; Flournoy N; Martin PJ; Sanders JE; Stewart P; Buckner CD; Storb R
N Engl J Med; 1985 Sep; 313(13):765-71. PubMed ID: 3897863
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
[TBL] [Abstract][Full Text] [Related]
15. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.
Beatty PG; Hansen JA; Longton GM; Thomas ED; Sanders JE; Martin PJ; Bearman SI; Anasetti C; Petersdorf EW; Mickelson EM
Transplantation; 1991 Feb; 51(2):443-7. PubMed ID: 1994541
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank].
Matsumoto K; Horibe K; Akatsuka Y; Minami S; Matsuyama T; Hirabayashi N; Tanimoto M; Yamada H; Sobue R; Morishima Y
Rinsho Ketsueki; 1994 Aug; 35(8):729-37. PubMed ID: 7933558
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors.
Lundberg JH; Hansen RM; Chitambar CR; Lawton CA; Gottlieb M; Anderson T; Ash RC
J Clin Oncol; 1991 Oct; 9(10):1848-59. PubMed ID: 1919635
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.
Grunebaum E; Roifman CM
Immunol Allergy Clin North Am; 2010 Feb; 30(1):63-73. PubMed ID: 20113887
[TBL] [Abstract][Full Text] [Related]
19. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
20. Marrow transplantation using volunteer unrelated donors in a comparison of mismatched family donor transplants: a Seattle perspective.
Beatty PG
Bone Marrow Transplant; 1994; 14 Suppl 4():S39-41. PubMed ID: 7728123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
